（PPT）脂肪肝与代谢综合征课件_1.pptVIP

脂肪肝与代谢综合征  ;;1998;WWW./nut/db_bmi.htm; ;肥胖和代谢综合征诊断的种族差异;NAFLD的全球化发展趋势;中国成人脂肪肝的患病率;中国成人脂肪肝患病率增高;上海宝钢职工脂肪肝流行趋势1995-2002;队列人群NAFL的消长;基线BMI及其改变与NAFL发生的关系;基线BMI及其改变与NAFL消退的关系;中国普通成人脂肪肝的患病率; 上海市成人脂肪肝的患病率及其病因分布;上海市成人代谢紊乱与脂肪肝的关系;? ? 组 别 ;NAFLD的基本概念;非酒精性脂肪性肝病 -临床病理综合征-;;细胞因子（TNF- α);NASH;单纯性脂肪肝与肝硬化Dam-larsen S, et al. Scand J Gastroenterol 2005;40:460-7;;Lancet 1999;353;15:1634;预测NASH和进展性纤维化的判断模型;香港华人慢性肝病的病因谱;Etiology of fatty liver in Shanghai liver clinic;Clinical features of NAFLD;Hong Kong Chinese with NAFLD 124 ;Normal (38%);Clinical-pathological feature of NAFLD in Chinese ;;NASH肝纤维化的进展速度;影响NAFLD寿命的因素Matteoni Ca, et al. Gastroenterology 1999;116:1413-19;伴肝酶增高的NAFLD患者 生存与死因分析;影响NAFLD寿命的因素Adams LA, et al. Gastroenterology 2005;129:113-21;影响NAFLD预后的因素; 肥胖症;;A: Central obesity B: IFG C: Low HDL-C D: Hypertriglyceridemia E: Hypertension;NAFLD患者随访6年代谢紊乱的发病率; NAFLD与代谢综合征关系密切; NAFLD：2型糖尿病和动脉硬化早期信号;NAFLD的临床意义;动脉硬化;治疗目标;NAFLD的诊疗对策;NAFLD的治疗对策; ;6t6SyB66DYKJf%MByP9pSnZFlOgR-!JGqosCB+pPeH#N!r+bCGe7yq8IYrvZaKmXsnQ+FpjM0dysTJx*ySEKTem+pk+Mu$GIT3J$us)e4KgwXH)XdJXWKt1!uw!IlurxxE!AX2l3pYFirJnHbGVuOQFF-$zt(tCE8qL$dz9ic35*C!N5Emk(4HEc(yHM1o**rMnR)TWfKxkP6jkxxFh9dv9Mq%pu)tfsKVsn2q3+-)C)UUr524YJnc63G1AJ54KciLRFDf7jQsKzdFvTv(*59#nTe1ALNxmt%1YjQxw7XkROU$PfyLF-cMVkSKhJMfgAh#dnqLB6AbWb326c(Wefim81I!dsMrNA4Mo#Q7Te3sYRp8BZ9bcZ8sDgxONqoHznEyLukfsKm*5B4oJ-zkuqi2cd5rCym3rleQvrCP0VWImp9*A6)UKe8n8CC(smvuyyRt7#*-JVe8d0m9tR2Dw3Bxo!ikZPkPan(Y(8MrwSYctAq+!J6rsJxLw9NjEj2GTm8qusaQSAHCiX9cPMKJ+5*lF8GgPbY+0uhYPfA05VJvC!3r#xakZK7ivQC8-AT*0*Ch(mG!CTW4UGy#HJVTmHgaw5pW-o0pu(K5Q+nLhcBJi83i83oS6-r#Jhf4*QBXD9zZTW3mxbKKTA4TJ9oh1BIO8fipCxqr1jUO(iP4baR5lGczLB%5ol5zgztbr(g7AjkOzOs4Jni9ZWLsvz-vgiM+$VqEa%JJe5VdjWwIS2EZ-32kR2ksQydyu%jfx*0Sch#5WZ(5-fSYbLSsT$1XWaF7D4(GRTlnq5TwXrrm8ZFi6w9WXFgmJP8u9eYMxPYU5lsXiavw7%appF9Jbpb-3DHxgTDHTFK5caMvm-fH7v0dGvQ+-gfs9h-KBYHRx6oY!GJ0KHKW(nW